Age-Dependent Management | AVN Prevention Critical | Early Diagnosis Essential | 95% Success with Pavlik
- Age determines treatment: 0-6mo = Pavlik, 6-18mo = closed reduction, 18mo-3yr = open reduction, over 3yr = open reduction + osteotomy
- AVN is most devastating complication - always results from treatment, not disease. Prevention: avoid forced abduction over 55°, human position in spica
- Pavlik harness positioning: Flexion 100-110°, abduction 50-70°, wear 23 hours/day, monitor with ultrasound every 3-4 weeks
- Safe zone concept: Range between redislocation and AVN risk positions. Must be at least 25° for closed reduction to succeed
- Graf ultrasound classification: Type I (normal), II (immature/dysplastic), III (subluxed), IV (dislocated)
- “Know age-based treatment algorithm - examiners frequently test this
- “AVN prevention is key - describe human position (100° flexion, 40-50° abduction, neutral rotation)
- “Pavlik harness failure: discontinue if not reduced by 3-4 weeks to prevent AVN
- “Obstacles to reduction: psoas, ligamentum teres, pulvinar, limbus, transverse acetabular ligament, capsule, adductors
Treatment is age-dependent. 0-6 months: Pavlik harness (95% success). 6-18 months: Closed reduction + spica. 18 months-3 years: Open reduction. Over 3 years: Open reduction + osteotomy. Never use Pavlik over 6-7 months.
AVN always results from treatment, not disease. Prevention: avoid abduction over 55°, use human position in spica (100° flexion, 40-50° abduction, neutral rotation), discontinue Pavlik if not reduced by 3-4 weeks. AVN rates: Pavlik 5-10%, closed reduction 20%, open reduction 10-20%.
Positioning: Flexion 100-110° (anterior strap), abduction 50-70° (posterior strap). Wear 23 hours/day initially. Monitor with ultrasound every 3-4 weeks. Discontinue if not reduced by 3-4 weeks (AVN risk increases).
Safe zone: Range between redislocation and AVN risk positions. Must be at least 25° for closed reduction to succeed. Assessed with arthrogram during EUA. Adductor tenotomy widens safe zone if narrow.
- Treatment
- Pavlik harness
- Key Principles
- Flexion 100-110°, abduction 50-70°, monitor with USS
- Success Rate
- 95% success
- Treatment
- Closed reduction + spica
- Key Principles
- EUA with arthrogram, safe zone over 25 degrees, human position
- Success Rate
- 80-90% success
- Treatment
- Open reduction
- Key Principles
- Medial (under 12mo) or anterior (over 12mo) approach
- Success Rate
- 85-90% success
- Treatment
- Open reduction + osteotomy
- Key Principles
- Femoral shortening/varus + pelvic osteotomy
- Success Rate
- 70-80% success
BREECHDDH Risk Factors
Hook:BREECH babies and females are at highest risk for DDH!
PLACTSObstacles to Reduction
Hook:PLACTS - all obstacles must be addressed for successful reduction!
FLEX ABDPavlik Harness Positioning
Hook:FLEX ABD - proper positioning prevents AVN and ensures success!
Overview and Epidemiology
Developmental dysplasia of the hip is the most common hip disorder in infants. Early diagnosis and age-appropriate treatment are essential to prevent long-term disability, AVN, and early osteoarthritis. Understanding the age-based treatment algorithm and AVN prevention strategies is critical for exam success.
- Incidence: 1 in 1000 live births
- Gender: Female predominance 7:1 (relaxin sensitivity)
- Laterality: Left hip 60% (fetal position), bilateral 20%
- Risk factors: Breech (20% vs 2% population), family history (12%), firstborn, packaging disorders
- Ethnicity: Higher in Caucasian, Lapland, Native American populations
- 1 in 60 abnormal at birth but 60% stabilize by 1 week, 88% by 2 months
- Untreated DDH: Leads to abnormal gait, limb shortening, early osteoarthritis
- Early treatment: Excellent outcomes with 95% success in Pavlik harness
- Late treatment: Worse outcomes, higher AVN risk, may require multiple surgeries
Pathophysiology and Mechanisms
DDH represents a spectrum from mild acetabular dysplasia to complete dislocation. Pathoanatomy includes: shallow acetabulum, labral hypertrophy and inversion, capsular laxity, ligamentum teres elongation, pulvinar (fibrofatty tissue) development in acetabulum, and secondary femoral head changes. Understanding these changes guides treatment approach.
- Normal
- Deep, covers 50%+ of head
- DDH Changes
- Shallow, covers less than 50%
- Clinical Significance
- Reduced coverage, instability
- Normal
- Normal size, everted
- DDH Changes
- Hypertrophied, inverted
- Clinical Significance
- Blocks reduction, requires release
- Normal
- Normal tension
- DDH Changes
- Lax, hourglass constriction
- Clinical Significance
- Prevents reduction, requires release
- Normal
- Normal size
- DDH Changes
- Elongated, hypertrophied
- Clinical Significance
- Obstacle to reduction, excise
- Normal
- Minimal
- DDH Changes
- Fibrofatty tissue in acetabulum
- Clinical Significance
- Obstacle to reduction, excise
- Normal
- Spherical, centered
- DDH Changes
- May be flattened, displaced
- Clinical Significance
- Secondary changes from dislocation
- Normal: Acetabular index 30° at birth, decreases to 20° by 24 months
- DDH: Elevated acetabular index, shallow acetabulum
- Remodeling potential: Up to 5 years of age
- After 5 years: Limited remodeling, may need osteotomy
- Early: May be normal if recently dislocated
- Chronic: Flattening, loss of sphericity
- Ossification: Delayed in dislocated hip
- After reduction: May remodel if reduced early
Classification Systems

Graf Classification (Ultrasound)
- Alpha Angle
- Over 60°
- Beta Angle
- Under 60°
- Description
- Normal hip
- Treatment
- Observation
- Alpha Angle
- 43-60°
- Beta Angle
- 55-77°
- Description
- Immature or dysplastic
- Treatment
- Monitor or Pavlik
- Alpha Angle
- Under 43°
- Beta Angle
- Over 77°
- Description
- Subluxed
- Treatment
- Pavlik harness
- Alpha Angle
- Under 43°
- Beta Angle
- Over 77°
- Description
- Dislocated
- Treatment
- Pavlik harness
Alpha angle (bony acetabular coverage): Normal over 60°. Beta angle (cartilaginous coverage): Normal under 60°. Type III and IV require treatment with Pavlik harness. Ultrasound is imaging modality of choice under 4-6 months (cartilaginous head not visible on X-ray).
Clinical Assessment
- Ortolani test: Abduction and gentle pressure over GT - clunk indicates reduction
- Barlow test: Adduction and posterior pressure - clunk indicates subluxation
- Reliability: Unreliable after 2-3 months as soft tissues tighten
- Other signs: Asymmetric creases, limited abduction (under 60°), Galeazzi sign (unilateral only)
- Limited abduction: Primary sign after 3 months
- Limb length discrepancy: Unilateral cases
- Gait abnormality: Waddling gait in bilateral, Trendelenburg in unilateral
- Asymmetric skin creases: May be present but not diagnostic
- Key Findings
- Ortolani/Barlow positive
- Tests
- Ortolani, Barlow tests
- Reliability
- Reliable
- Key Findings
- Limited abduction
- Tests
- Abduction ROM, Galeazzi sign
- Reliability
- Moderately reliable
- Key Findings
- Limp, LLD, limited ROM
- Tests
- Gait assessment, ROM
- Reliability
- Less reliable - imaging key
Investigations
- Timing: Most useful from 4-6 weeks until femoral head ossifies
- Graf classification: Alpha angle (bony coverage, normal over 60°), beta angle (cartilaginous, normal under 60°)
- Dynamic assessment: Evaluates stability during movement
- Monitoring: Repeat every 3-4 weeks during Pavlik treatment
- AP pelvis: Assess acetabular index, Shenton's line, head position
- Frog-leg lateral: Assess femoral head coverage, version
- Measurements: Acetabular index (normal under 30° at 1 year), center-edge angle (after age 5)
- Normal findings: Sharp labrum (rose thorn sign), minimal medial pooling
- Abnormal findings: Widened medial joint space (pooling over 5mm), blunted labrum, hourglass constriction
- Safe zone assessment: Determines abduction range maintaining reduction without AVN risk

Differential Diagnosis
- Key Distinguishing Feature
- Reducible/dislocatable, shallow acetabulum, no fixed deformity
- Investigation
- Ultrasound (Graf), AP pelvis
- Why It Matters
- Index diagnosis - reversible if treated early
- Key Distinguishing Feature
- Fixed, irreducible at birth; syndromic (arthrogryposis, myelomeningocele)
- Investigation
- Exam, screen for neuromuscular cause
- Why It Matters
- Will NOT respond to Pavlik; needs surgery and a different prognosis
- Key Distinguishing Feature
- Short femur, abnormal proximal femur, not simply dislocated
- Investigation
- Radiograph of whole femur
- Why It Matters
- Limb reconstruction problem, not a reduction problem
- Key Distinguishing Feature
- Pain, fever, raised inflammatory markers, pseudoparalysis
- Investigation
- Aspiration, bloods, ultrasound effusion
- Why It Matters
- Surgical emergency; late sequela can mimic dysplasia
- Key Distinguishing Feature
- Decreased neck-shaft angle, vertical physis, Trendelenburg
- Investigation
- AP pelvis (Hilgenreiner-epiphyseal angle)
- Why It Matters
- Femoral-side problem, different osteotomy
- Key Distinguishing Feature
- Spasticity, progressive subluxation, GMFCS-related
- Investigation
- Hip surveillance radiographs (migration %)
- Why It Matters
- Salter contraindicated; needs Dega-type and soft-tissue surgery
A teratologic dislocation is irreducible from birth and is associated with arthrogryposis, myelomeningocele and other syndromes. Attempting Pavlik or forced closed reduction wastes time and risks AVN. Always examine for fixed deformity, contractures and neurological signs before committing to conservative reduction.
Management Algorithm
Treatment Algorithm by Age
0-6 Months: Pavlik Harness
- First-line treatment for dislocatable/dislocated hips
- Positioning: Flexion 100-110°, abduction 50-70°
- Wear 23 hours/day initially, wean over 2-4 months
- Monitor with ultrasound every 3-4 weeks
- Success rate: 95% for Graf III/IV detected early
- Discontinue if not reduced by 3-4 weeks (AVN risk)
6-18 Months: Closed Reduction
- Examination under anaesthesia with arthrogram
- Assess reduction quality and safe zone
- Adductor tenotomy if safe zone narrow (under 25°)
- Spica cast: 100° flexion, 40-50° abduction, neutral rotation
- Cast for 3 months, change at 6 weeks
- Success rate: 80-90% if adequate safe zone
18 Months-3 Years: Open Reduction
- Indicated when closed reduction fails
- Medial approach (Ludloff, Ferguson) under 12 months
- Anterior approach (Smith-Petersen) over 12 months
- Address obstacles to reduction
- May need femoral shortening if tight
Over 3 Years: Open Reduction + Osteotomy
- Open reduction always required
- Femoral varus and shortening osteotomy
- Pelvic osteotomy for residual dysplasia
- More complex, higher complication risk
This age-based approach ensures optimal outcomes while minimizing complications.
Surgical Technique

Pavlik Harness Application
- Graf Type III or IV (subluxed or dislocated)
- Age 0-6 months (maximum 6-7 months)
- Dislocatable hip on examination
- Chest strap: Around nipple line, snug but not tight
- Anterior strap: Controls flexion 100-110°
- Posterior strap: Controls abduction 50-70°
- Positioning: Hip flexed and abducted, allows active motion
- Ultrasound every 3-4 weeks
- Check for reduction, assess Graf type improvement
- Adjust straps as needed
- If reduced: Gradually wean over 2-4 months
- If not reduced by 3-4 weeks: Discontinue to prevent AVN
- Switch to closed reduction if Pavlik fails
- AVN (5-10%): From forced abduction, discontinue if not reduced
- Pavlik disease: Posterolateral acetabular wear from treatment in unreduced position
- Recurrence: ~10% after successful treatment
Proper application and monitoring are essential for success and AVN prevention.
Complications
Avascular Necrosis (Most Devastating)
- Pavlik harness: 5-10%
- Closed reduction: ~20% (Salter type 1)
- Open reduction: 10-20% (medial approach 10%, anterior approach 10-20%)
- Always results from treatment, not disease
- Forced abduction over 55°
- Extreme abduction with internal rotation and extension
- Multiple reduction attempts
- Early rigid casting
- Class I: Nucleus only - will be normal
- Class II: Lateral physis - coxa valga from lateral physeal fusion
- Class III: Central - moderate deformity
- Class IV: Whole physis - severe deformity, poor outcomes
- Avoid abduction over 55°
- Use human position in spica (100° flexion, 40-50° abduction, neutral rotation)
- Discontinue Pavlik if not reduced by 3-4 weeks
- Gentle reduction technique
- Avoid multiple reduction attempts
- Established AVN: Containment procedures, may need later salvage
- Monitor for growth disturbance, coxa magna, coxa breva, coxa vara
AVN prevention is the most important principle in DDH treatment.
The Spica Cast: Confirming Reduction and Avoiding Cast Complications
The topic repeatedly refers to the spica cast, the "human position", and an "immediate MRI in spica to confirm reduction", but never develops why post-reduction imaging is mandatory or the cast-specific complications - both are examinable, and getting the cast wrong is a direct cause of the AVN the whole topic warns against.
- Why image inside the cast - you must PROVE a concentric reduction. After a closed reduction the femoral head is hidden by plaster, and a hip that looks reduced on the table can be non-concentrically reduced or frankly re-dislocated once cast. Post-reduction cross-sectional imaging - CT (fast, low-dose limited slices) or MRI (no radiation, also shows the cartilaginous head and soft-tissue obstacles) - confirms the head is concentrically seated in the acetabulum. A non-concentric reduction (persistent medial gap/pooling) must not be accepted - it will fail and predisposes to dysplasia and AVN, so it mandates re-casting or open reduction rather than "waiting and hoping".
- Apply the cast in the safe "human position", never forced abduction. The spica is moulded in ~100° hip flexion, 40-50° abduction and neutral rotation - the same AVN-avoiding position emphasised throughout. Forced/extreme abduction to "hold" a borderline reduction is the classic error that occludes the posterosuperior head vessels and causes AVN (the Gardner review specifically linked ≥60° abduction immobilisation to AVN).
- Cast-specific complications to counsel and watch for. Vascular/neurological compromise of the limb (over-tight or over-abducted cast - check perfusion and the femoral nerve), pressure sores (bony prominences, cast edges - especially in the non-verbal infant), cast (superior mesenteric artery) syndrome with vomiting in body casts, skin maceration/soiling at the perineum, and loss of position/re-dislocation inside the cast. Cast changes are done under anaesthesia (typically at ~6 weeks) with re-check of position.
Q: After closed reduction and spica for DDH, what must you do and what must you avoid? A: Confirm a CONCENTRIC reduction with post-reduction CT or MRI in the cast - the head is hidden by plaster and a non-concentric/re-dislocated hip must be re-cast or opened, not accepted. Apply the cast in the "human position" (~100° flexion, 40-50° abduction, neutral rotation) and never force abduction to hold a borderline reduction (≥55-60° abduction causes AVN). Watch for cast complications: limb vascular/femoral-nerve compromise, pressure sores, cast syndrome, and loss of position; change the cast under anaesthesia.
Residual Acetabular Dysplasia After Reduction: the Remodelling Window and When to Add an Osteotomy
The topic notes that "residual dysplasia may occur despite successful reduction", that the "acetabular index should normalize by age 2-3 years", and that a persistently high index "may need later osteotomy" - but never develops the actual decision: how long to allow remodelling before intervening, and how to choose the operation. This is a classic paediatric-hip viva progression.
- A concentric reduction is itself the main treatment for the acetabulum. Acetabular development depends on a concentrically reduced femoral head providing the growth stimulus - so achieving and holding a concentric reduction lets the majority of acetabular dysplasia remodel spontaneously. The evolution (trajectory) of the acetabular index over serial radiographs is the best predictor of persistent dysplasia - an index that is steadily falling toward normal can be observed, whereas one that plateaus or stays high will not correct on its own.
- How long to wait - the remodelling window. Most acetabular improvement occurs in the first 18-24 months after reduction, with useful remodelling potential continuing to about 4-5 years. A reasonable rule is to observe with serial films while the index is improving, and to consider a pelvic (acetabular) procedure once it is clear that spontaneous correction has stalled (persistently elevated acetabular index / low centre-edge angle beyond the expected window, typically after ~age 3-5), rather than operating on every high index early.
- Choose the osteotomy by triradiate status and the deformity. With an open triradiate cartilage in a young child, a reshaping acetabuloplasty (Pemberton, hinging on the triradiate; Dega for posterior deficiency, e.g. neuromuscular) or a redirectional Salter innominate osteotomy (hinging on the pubic symphysis) is used; once the triradiate closes (adolescent/adult), a redirectional periacetabular [Ganz] osteotomy is required (developed in the periacetabular-osteotomy topic). A coexisting femoral deformity (excess anteversion/valgus) may need a varus derotation femoral osteotomy alongside.
- The reduction must be concentric and AVN-free first. As the long-term Salter data show, durability depends on a concentric, avascular-necrosis-free reduction - a pelvic osteotomy cannot rescue a non-concentric or AVN-damaged hip, so fix the reduction before, or reserve/stage, the osteotomy.
Q: A hip is reduced but the acetabulum is still dysplastic - when and how do you intervene? A: A concentric reduction stimulates acetabular remodelling, so most dysplasia corrects spontaneously - the trajectory of the acetabular index on serial films is the best predictor. Observe while the index is falling (most remodelling in the first ~18-24 months, potential to ~4-5 years); intervene with a pelvic osteotomy only once spontaneous correction has clearly stalled (persistently high index / low CEA, typically after ~3-5 years). Choose by triradiate status: Pemberton/Dega (reshaping) or Salter (redirectional) with an open triradiate; periacetabular [Ganz] osteotomy once it is closed; add a femoral VDRO for femoral deformity. Ensure the reduction is concentric and AVN-free first.
Postoperative Care
- Wear 23 hours/day initially
- Gradually wean over 2-4 months as hip stabilizes
- Monitor with ultrasound every 3-4 weeks
- Discontinue if not reduced by 3-4 weeks
- Parent education on application and care
- Duration: 3 months
- Change cast at 6 weeks
- Immediate MRI in spica to confirm reduction
- Cast care: Keep dry, check for pressure areas
- Monitor for cast problems, skin issues
- Spica cast for 3 months postoperatively
- Change cast at 6 weeks
- Monitor for AVN with serial radiographs
- Physiotherapy after cast removal
- Long-term follow-up for residual dysplasia
- Serial radiographs: 6 months, 1 year, 2 years, then annually until skeletal maturity
- Monitor for AVN, residual dysplasia, redislocation
- Acetabular index should normalize by age 2-3 years
- Center-edge angle assessment after age 5
Long-term follow-up is essential to monitor for AVN (may present late), residual dysplasia (may need later osteotomy), and redislocation. Serial radiographs monitor acetabular development and femoral head shape.
Outcomes and Prognosis
- Pavlik harness: 95% success if detected early (under 6 weeks)
- Closed reduction: 80-90% success if adequate safe zone
- Open reduction: 85-90% success
- Key factor: Early diagnosis and treatment
- Over 3 years: 70-80% success, higher complication rates
- Over 5 years: Limited remodeling potential
- Bilateral painless dislocations: May leave alone (controversial)
- Late diagnosis: Correlates with worse outcomes
- Success Rate
- 95%
- AVN Risk
- 5-10%
- Key Factors
- Early detection, proper positioning
- Success Rate
- 80-90%
- AVN Risk
- 20%
- Key Factors
- Adequate safe zone, human position
- Success Rate
- 85-90%
- AVN Risk
- 10-20%
- Key Factors
- Address all obstacles, gentle technique
- Success Rate
- 70-80%
- AVN Risk
- 15-25%
- Key Factors
- Complex, higher risk
Guidelines, Registries & Global Practice
- Incidence: Wide range (0.06 to 76 per 1000) depending on definition and screening intensity; clinically significant DDH ~1 per 1000
- Highest prevalence: Native American, Lapland/Sami, and other swaddling cultures (tight hip extension)
- Lowest prevalence: Populations carrying infants in abduction (parts of Africa and Asia)
- Consistent risk factors worldwide: Female sex, breech, family history, firstborn, oligohydramnios
- Clinical screening: Universal newborn Ortolani/Barlow is endorsed across all major societies
- Selective ultrasound: Risk-factor plus abnormal-exam based - UK NIPE, BOA, and most European programmes
- Universal ultrasound: Standard in Austria and parts of Germany/Switzerland (Graf); reduces late surgery but increases harness treatment
- AAOS (US): Conditional recommendation for imaging surveillance of at-risk infants rather than universal ultrasound
- Imaging Approach
- Selective imaging of at-risk infants; no universal ultrasound
- Treatment Emphasis
- Pavlik or rigid abduction brace first-line under 6 months
- Imaging Approach
- Universal clinical exam + selective ultrasound (risk factors, abnormal exam)
- Treatment Emphasis
- Brace under 6 months; closed/open reduction thereafter
- Imaging Approach
- Universal ultrasound screening of all newborns
- Treatment Emphasis
- Early ultrasound-guided abduction treatment, low late-surgery rate
- Imaging Approach
- Selective ultrasound with mandatory clinical screening
- Treatment Emphasis
- Avoid forced abduction; staged reduction by age and severity
DDH is the single largest cause of hip osteoarthritis requiring total hip arthroplasty in young adults, accounting for roughly 20-30% of THAs in patients under 60 in arthroplasty registry data (e.g. AOANJRR, NJR, Swedish Hip registry contexts). This long-term burden - not short-term reduction success - is the real justification for early diagnosis and AVN-avoiding treatment.
- High-resource settings: Newborn ultrasound capacity, early Pavlik, arthrogram-guided reduction, MRI-confirmed spica position, multidisciplinary follow-up to maturity
- Limited-resource settings: Reliance on clinical exam and late radiographs, higher rate of neglected/late-presenting dislocation, greater use of traction and open reduction with osteotomy
- Universal principle everywhere: Gentle concentric reduction in the human position, avoiding abduction over 55°, remains the AVN-avoidance standard regardless of resources
Controversies and Areas of Uncertainty
Universal newborn ultrasound reduces late-presenting dislocation and the need for surgery but markedly increases harness treatment (overtreatment of physiologically immature hips). Selective screening avoids overtreatment but depends on reliable clinical examination. No global consensus exists; practice tracks resources and historical programmes.
The Pavlik harness allows active motion within a safe range; rigid abduction braces (von Rosen, Tübingen, Plastazote) provide more fixed control. Evidence does not clearly favour one device, and rigid braces are often used as second-line after Pavlik failure or for non-compliant families rather than as proven superiors.
The classic teaching is to abandon the harness if the hip is not reduced within 3-4 weeks to limit AVN ("Pavlik disease"). Some series tolerate up to 6 weeks with a gentle progressive protocol. The unifying principle is that a persistently dislocated hip inside a harness causes posterior acetabular wear and must not be left.
For older children, whether to perform pelvic/femoral osteotomy at the same sitting as open reduction or in a staged fashion is debated. Long-term Salter data suggest performing open reduction first and reserving or staging osteotomy improves durability, but single-stage surgery is widely practised to limit anaesthetics.
In a walking child with bilateral, painless, completely dislocated hips presenting late (e.g. over 4-6 years), the morbidity of bilateral open reduction and osteotomy (stiffness, AVN, redislocation) may exceed the natural history of well-tolerated bilateral dislocation for many years. Whether to operate, operate on one side, or observe remains genuinely controversial and is individualised to symptoms, function and family expectations.
MCQ Practice Points
Q: What is the success rate of Pavlik harness for Graf Type III/IV DDH when initiated early (under 6 weeks)? A: 95% - Pavlik harness achieves 95% success rate when initiated early. Success drops to 80% if started after 7 weeks.
Q: The most devastating complication of DDH treatment is: A: Avascular necrosis (AVN) - AVN is the most devastating complication, causing femoral head deformity and growth disturbance. It always results from treatment, not disease.
Q: What is the maximum abduction angle in spica cast to minimize AVN risk? A: 55° - Abduction over 55° significantly increases AVN risk. Human position uses 40-50° abduction to minimize risk.
Q: At what age does acetabular remodeling potential significantly decrease? A: 5 years - Acetabular remodeling potential exists up to 5 years. After this, limited remodeling occurs and osteotomy may be required.
Q: Which approach is preferred for open reduction of DDH in a 10-month-old child? A: Medial approach (Ludloff/Ferguson) - Preferred under 12 months as it preserves blood supply and has lower AVN risk (10% vs 10-20% for anterior).
Q: What is the minimum safe zone required for successful closed reduction? A: 25° - Safe zone under 25° is associated with high failure and AVN risk. Adductor tenotomy may widen safe zone.
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A 3-month-old infant presents with Graf Type IV DDH (dislocated hip). You decide to use Pavlik harness. Describe your management approach including positioning, monitoring, and when you would discontinue treatment.”
“An 8-month-old infant with DDH failed Pavlik harness treatment. You perform examination under anaesthesia with arthrogram. The arthrogram shows medial pooling of 8mm and a safe zone of only 15°. Discuss your management.”
“A 2.5-year-old child presents with untreated unilateral DDH. The hip is dislocated and irreducible. Discuss your management approach including surgical technique and expected outcomes.”
Age-Based Treatment Algorithm
- 0-6 months: Pavlik harness (95% success if early)
- 6-18 months: Closed reduction + spica (80-90% success)
- 18 months-3 years: Open reduction (85-90% success)
- Over 3 years: Open reduction + osteotomy (70-80% success)
Pavlik Harness Management
- Positioning: Flexion 100-110°, abduction 50-70°
- Wear: 23 hours/day initially
- Monitoring: Ultrasound every 3-4 weeks
- Discontinue if not reduced by 3-4 weeks (prevents AVN)
- Success rate: 95% if detected early (under 6 weeks)
AVN Prevention - Critical Principles
- Human position: 100° flexion, 40-50° abduction, neutral rotation
- Never exceed 55° abduction (significantly increases AVN risk)
- Gentle reduction - forced reduction causes AVN
- Discontinue Pavlik promptly if reduction fails
- AVN always results from treatment, not disease
Safe Zone and Closed Reduction
- Safe zone: Range between redislocation and AVN risk
- Minimum 25° required for closed reduction success
- Medial pooling over 7mm = poor outcome predictor
- Adductor tenotomy may widen safe zone
- If safe zone inadequate after tenotomy → open reduction
Obstacles to Reduction
- Psoas tendon (release)
- Ligamentum teres (excise)
- Pulvinar (excise)
- Inverted limbus (may need release)
- Transverse acetabular ligament (release)
- Capsule hourglass constriction (incise)
- Adductors (tenotomy)
Graf Classification
- Type I: Normal (alpha over 60°, beta under 60°)
- Type II: Immature (may resolve)
- Type III: Subluxed (needs treatment)
- Type IV: Dislocated (needs treatment)
- Ultrasound under 4-6 months (cartilaginous head)
Open Reduction Approaches
- Medial approach (Ludloff/Ferguson): Under 12 months, 10% AVN risk
- Anterior approach (Smith-Petersen): Over 12 months, 10-20% AVN risk
- Medial preserves blood supply better in infants
- Anterior allows pelvic osteotomy if needed
Pelvic Osteotomies
- Salter: Redirectional, young children
- Pemberton: Reshaping, under 8 years
- PAO (Periacetabular Osteotomy): Adolescent/adult
- Indicated if acetabular index over 30° or center-edge angle under 20°
AVN Rates by Treatment
- Pavlik harness: 5-10%
- Closed reduction: 20%
- Open reduction: 10-20%
- Late presentation: Higher complication rates
- AVN is most devastating complication
Key Principles
- Early diagnosis and treatment essential
- 95% success with Pavlik if detected early
- Age-based treatment algorithm critical
- AVN prevention is paramount
- Address all obstacles to reduction
Evidence Base
Pavlik Harness Success and Failure Predictors
- Overall Pavlik success 83.4% across all Graf types
- Earlier start (mean 6.7 vs 8.8 weeks) favours success
- Frank dislocation and Graf III/IV independently predict failure
- Femoral nerve palsy is a marker of excessive flexion and impending failure
Pavlik Harness in the Late-Diagnosed Dislocated Hip (6-24 Months)
- Graf III hips can still reduce in older infants (60%)
- Graf IV (frankly dislocated) success was 0% - do not persist
- No AVN in successfully reduced hips with gentle progressive technique
- Abandon the harness if not reduced by ~6 weeks
Risk Factors for Failed Pavlik Reduction
- Higher initial dislocation (small distance A) predicts failure
- Acetabular angle over 36° predicts failure
- Age over 4 months at application predicts failure
- Quantifies the case selection that favours Pavlik success
AVN After Medial Open Reduction - Systematic Review
- Medial open reduction AVN rate ~20% (24% at maturity)
- AVN nearly triples the unsatisfactory outcome rate
- Immobilisation at 60° abduction or more increases AVN
- Surgery under 12 months independently increases AVN risk
Salter Innominate Osteotomy - 26-35 Year Follow-up
- 90% survival of the Salter osteotomy at 35 years
- AVN and residual dysplasia drive long-term failure
- Higher dislocation grade predicts worse outcome
- Stage open reduction before pelvic osteotomy when both needed
Universal vs Selective Ultrasound Screening
- Selective screening did not increase true late diagnoses
- Universal screening increases treatment rate (overtreatment)
- Universal screening shifts treatment earlier and less invasive
- Trade-off between overtreatment and avoiding late surgery
DDH Management - Contemporary Review (AVN Mechanisms)
- ~90% of mild neonatal instability resolves by 8 weeks
- Ortolani-positive hip requires immediate treatment
- AVN linked to excessive abduction and forced reduction
- Acetabular index evolution best predicts residual dysplasia